Komori
New Japan Chemical (4406) · InitiativeAdvanced

Product development using proprietary technologies, including hydrogenation technology

First written in FY2017. 8 of 15 entries say "Restated". Latest entry: FY2026.

15entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2020-Q1AdvancedFY2020 – FY2022-Q2RestatedFY2022-Q3AdvancedFY2024 – FY20262017: 320172018: 420182019: 220192020: 120202021: 120212022: 120222023: 020232024: 120242025: 120252026: 12026
Same theme, other companies
Creation of High-Value-Added Products Based on Materials and Core TechnologiesA theme 126 companies write about · 0 as a headwind · 156 as a tailwind

64 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 126 companies compared. The sentences above are computed from all 126.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The company is also developing dianhydrides for photosensitive polyimide used in display and semiconductor applications. In recent years, inquiries for the Ricacid® series of dianhydrides for photosensitive polyimide applications and as PFAS alternatives have increased. To respond to further technological innovation in this field, the company will conduct photosensitivity evaluations in-house and propose not only the products as monomers but also functions that can be added to polyimides, such as transparency, flexibility and solvent solubility.」

    The company's product development using proprietary technologies has expanded in response to increased inquiries for dianhydrides, including proposals for functionality based on in-house photosensitivity evaluations.
  2. FY2025AdvancedAnnual report

    「Sales of the special aromatic dianhydride for organic EL materials, for which plant prototyping was completed in the 152nd fiscal year, have continued steadily. The research and development division is considering increasing production capacity and designing new facilities in preparation for future market expansion.」

    The special aromatic dianhydride has progressed through plant prototyping and customer adoption to the stage of continued sales, and the company is moving forward with increasing production capacity and designing new facilities for future market expansion.
  3. FY2024AdvancedAnnual report

    「The company's proprietary special aromatic dianhydrides are seeing new adoption and rapidly expanding demand as materials for organic EL applications and insulating encapsulation resins for EV motors. Improvements in manufacturing processes and analytical methods have enabled the company to meet customers' stringent quality requirements, and it plans to expand into the electrical and electronics fields and others.」

    The company reports new adoption and expanding demand for its proprietary special aromatic dianhydrides as organic EL materials and insulating encapsulation resins for EV motors.
  4. FY2022-Q3RestatedAnnual report

    「In line with the business strategies set out in the medium-term management plan launched in April 2021, the company is expanding sales of high-value-added products such as resin raw materials for mobility and electronic materials and resin modifiers for medical equipment.」

    The company continues to expand sales of high-value-added products using its proprietary technologies for mobility, electronic materials and medical equipment.
  5. FY2022-Q2AdvancedAnnual report

    「In addition to revising prices in response to higher raw-material prices, we actively worked to expand sales of functional materials, including resin raw materials for mobility and electronic materials and resin modifiers for medical devices, resulting in increased sales.」

    The company states that it actively expanded sales of functional materials for mobility, electronic materials and medical equipment using its proprietary technologies, leading to increased sales.
  6. FY2020AdvancedAnnual report

    「For hydrogenation products, the company proposes various cycloaliphatic compounds with controlled three-dimensional structures by combining its core technologies of selective hydrogenation and separation and purification. These products have been adopted as raw materials for electronic materials such as liquid-crystal panels and as raw materials for polymerization catalysts for environmentally compatible polyolefins. In addition to expanding its own products, the company is actively pursuing contract hydrogenation and has established an operating environment capable of handling volumes ranging from several hundred kilograms to several hundred tonnes.」

    Applications of hydrogenation technology have expanded to raw materials for electronic materials and polymerization catalysts. The company reports a track record of adoption and an operating environment capable of handling contract hydrogenation volumes ranging from several hundred kilograms to several hundred tonnes.
  7. FY2020-Q1RestatedAnnual report

    「Amid these conditions, our group advanced initiatives to build a highly profitable corporate structure, including strengthening the profitability of its existing and contract businesses, accelerating development of high-value-added products applying core technologies including hydrogenation technology, and making focused investments in business fields with growth potential.」

    The company continues to accelerate the development of high-value-added products by applying core technologies including hydrogenation technology.
  8. FY2019-Q3RestatedAnnual report

    「To expand the high-value-added products business, we focused on developing new products applying our core hydrogenation technology.」

    The company continues to develop high-value-added products through new product development based on its core hydrogenation technology.
  9. FY2019-Q2RestatedAnnual report

    「Against this backdrop, the Group promoted expansion of its high-value-added product business by using internal and external resources, including actively pursuing new product development based on its core hydrogenation technology and collaboration with other companies.」

    The company continues to expand its high-value-added product business through new product development based on its core hydrogenation technology and collaboration with other companies.
  10. FY2019-Q1RestatedAnnual report

    「We promoted the expansion of the high-value-added products business by using internal and external resources, including actively pursuing new product development applying our core hydrogenation technology and collaboration with other companies.」

    The company continues to pursue a policy of using new product development based on its core hydrogenation technology to expand its high-value-added product business.
  11. FY2018AdvancedAnnual report

    「For hydrogenation products, the company proposes various cycloaliphatic compounds with controlled three-dimensional structures by combining its core technologies of selective hydrogenation and separation and purification. These products have been adopted as intermediates for electronic materials and pharmaceuticals and agrochemicals. The company is proceeding with expanding its hydrogenation product lineup and developing new synthesis processes.」

    For products related to hydrogenation technology, the company reports adoption as raw materials for electronic materials and pharmaceutical and agrochemical intermediates, and has progressed to expanding the product lineup and developing new processes.
  12. FY2018-Q3RestatedAnnual report

    「In Functional Chemicals, net sales exceeded the previous year, mainly because hydrogenation-related products, functional esters, and lubricants for automotive applications performed well.」

    The company continues to report strong sales of products based on its proprietary technologies, including hydrogenation-related products, and performance exceeding the previous year.
  13. FY2018-Q2RestatedAnnual report

    「In Functional Chemicals, hydrogenation-related products, functional esters, and lubricants for automotive applications performed well, with both sales volume and net sales exceeding the previous year.」

    The company continues to report strong sales of products based on its proprietary technologies, including hydrogenation-related products, with volumes and sales exceeding the previous year.
  14. FY2018-Q1RestatedAnnual report

    「In Functional Chemicals, sales of specialty oils and functional esters, both newly developed products, as well as lubricants for automotive applications and hydrogenation-related products remained strong, resulting in increases in both volume and net sales.」

    The company continues to report strong sales of products based on its proprietary technologies, including hydrogenation-related products.
  15. FY2017First statedAnnual report

    「We will develop products using proprietary technologies with competitive advantages, including hydrogenation technology, and prevail in competition in the chemical industry.」

    The company has for the first time explicitly stated a strategy of using proprietary technologies centered on hydrogenation technology as the foundation for product development.
Moved together

"Ongoing Research and Development Activities" moved the same way as this thread, in the same document, in 5 of its 15 moves.

554444★123456
  1. ★This thread
  2. 1Ongoing Research and Development Activities5×
  3. 2Developing and commercialising new products that address market needs5×
  4. 3Increasing overseas sales and expanding market share4×
  5. 4Developing products in harmony with the global environment4×
  6. 5Renewal of existing production facilities and capital expenditures4×
  7. 6Exploration of biomass-derived raw materials4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
New Japan Chemical's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.